Frequently searched
↑ ↓ to move · Enter to open · Esc to closeSynonyms and typos are matched
Trial site
Recruiting
Evaluate REC-4881 in Participants With Familial Adenomatous Polyposis (FAP)
NCT05552755· Phase 1/2· Recursion Pharmaceuticals Inc.· Source
Contact: Casey Koza
Site data: ClinicalTrials.govUpdated 12 Nov 2026
Report an error